Evidence map›Paper›PMID 31998772›Full record

ArticleBioMed research international2019

Particle Swarm Optimized Hybrid Kernel-Based Multiclass Support Vector Machine for Microarray Cancer Data Analysis.

Davies Segera, Mwangi Mbuthia, Abraham Nyete

Abstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Davies SegeraDepartment of Electrical and Information Engineering, University of Nairobi, Nairobi 30197, Kenya.ORCID https://orcid.org/0000-0002-4243-6801
Mwangi MbuthiaDepartment of Electrical and Information Engineering, University of Nairobi, Nairobi 30197, Kenya.
Abraham NyeteDepartment of Electrical and Information Engineering, University of Nairobi, Nairobi 30197, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determining an optimal decision model is an important but difficult combinatorial task in imbalanced microarray-based cancer classification. Though the multiclass support vector machine (MCSVM) has already made an important contribution in this field, its performance solely depends on three aspects: the penalty factor C, the type of kernel, and its parameters. To improve the performance of this classifier in microarray-based cancer analysis, this paper proposes PSO-PCA-LGP-MCSVM model that is based on particle swarm optimization (PSO), principal component analysis (PCA), and multiclass support vector machine (MCSVM). The MCSVM is based on a hybrid kernel, i.e., linear-Gaussian-polynomial (LGP) that combines the advantages of three standard kernels (linear, Gaussian, and polynomial) in a novel manner, where the linear kernel is linearly combined with the Gaussian kernel embedding the polynomial kernel. Further, this paper proves and makes sure that the LGP kernel confirms the features of a valid kernel. In order to reveal the effectiveness of our model, several experiments were conducted and the obtained results compared between our model and other three single kernel-based models, namely, PSO-PCA-L-MCSVM (utilizing a linear kernel), PSO-PCA-G-MCSVM (utilizing a Gaussian kernel), and PSO-PCA-P-MCSVM (utilizing a polynomial kernel). In comparison, two dual and two multiclass imbalanced standard microarray datasets were used. Experimental results in terms of three extended assessment metrics (

Indexed as

Data AnalysisNeoplasmsSupport Vector MachineAlgorithmsHumansLinear ModelsMicroarray AnalysisModels, StatisticalPrincipal Component Analysis

Identifiers

PMID31998772
PMCPMC6973196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.